Rapid prescribing change, how do patients respond?
- PMID: 8961398
- DOI: 10.1016/s0277-9536(96)00050-0
Rapid prescribing change, how do patients respond?
Abstract
The cost of prescribed medication is an increasing burden on health care systems. British general practitioners have been encouraged to reduce their prescribing costs through financial incentives within the fundholding scheme. This study reports on one general practice which reduced prescribing expenditure as part of the move to fundholding. Interviews performed with practice staff and patients were analysed and combined with prescribing statistics and questionnaire data to give a picture of the balance between the experience of patients and practitioners. Fifty-three interviews with 17 patients revealed that most were willing to try cheaper treatments and that dissatisfaction was primarily with the communication they received rather than the change itself. Each patient had to decide how to respond to the change in their medication. The decision-making process and the main factors involved are described and discussed. The experience of having long-standing treatment changed can have an impact on the doctor-patient relationship. This was not found to be a large problem and, it is suggested, can be guarded against. Large-scale economies in prescribing are feasible for some practices, and patients will tolerate such changes if attention is paid to sensitive communication.
Similar articles
-
Changing to generic formulary: how one fundholding practice reduced prescribing costs.BMJ. 1995 Feb 25;310(6978):505-8. doi: 10.1136/bmj.310.6978.505. BMJ. 1995. PMID: 7677830 Free PMC article.
-
A prescribing incentive scheme for non-fundholding general practices: an observational study.BMJ. 1996 Aug 31;313(7056):535-8. doi: 10.1136/bmj.313.7056.535. BMJ. 1996. PMID: 8789984 Free PMC article.
-
GP fundholding and the costs of prescribing: further results.J Public Health Med. 1997 Mar;19(1):18-22. doi: 10.1093/oxfordjournals.pubmed.a024580. J Public Health Med. 1997. PMID: 9138212
-
Current prescribing in primary care in the UK. Effects of the indicative prescribing scheme and GP fundholding.Pharmacoeconomics. 1995 Apr;7(4):320-31. doi: 10.2165/00019053-199507040-00006. Pharmacoeconomics. 1995. PMID: 10155321 Review.
-
Medication prescribing advice and drug utilization: a review from the United Kingdom.Pharm Pract Manag Q. 1996 Jan;15(4):27-35. Pharm Pract Manag Q. 1996. PMID: 10153842 Review.
Cited by
-
Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma.Postgrad Med J. 1999 Dec;75(890):710-4. doi: 10.1136/pgmj.75.890.710. Postgrad Med J. 1999. PMID: 10567594 Free PMC article.
-
Lessons from the failure of implementing the 'Better Care Better Value' prescribing indicator for renin-angiotensin system drugs in England: a qualitative study of general practitioners' perceptions using behavioural change framework.BMJ Open. 2020 Jun 23;10(6):e035910. doi: 10.1136/bmjopen-2019-035910. BMJ Open. 2020. PMID: 32580986 Free PMC article.
-
Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial.Drugs Aging. 2001;18(2):143-9. doi: 10.2165/00002512-200118020-00007. Drugs Aging. 2001. PMID: 11346128 Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources